R&D Why the future of eSource starts with the research site Capturing data digitally at source can significantly reduce the workflow for sites, yet, implementing it across studies has been rather unattainable.
Partner Content Partner Content What the Best Clinical Study Build Pros Do (and You Should T... Master Clinical Study Build with ryze!
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.